Special Issue "Novel Molecular Targets for Cardioprotection: The EU-CARDIOPROTECTION COST Action (CA16225)"
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (1 April 2019).
Interests: cardiovascular pharmacology and toxicology; myocardial ischemic pre- and postconditioning (cardioprotection); oxidative stress in ischemia–reperfusion injury; molecular toxicology
Special Issues and Collections in MDPI journals
2. The Hatter Cardiovascular Institute,Institute of Cardiovascular Sciences, University College London, 67 Chenies Mews, London WC1E 6HX, UK
Interests: cardioprotection; myocardial ischemic preconditioning and postconditioning; ischemia-reperfusion injury; mitochondria as targets for cardioprotection; remote ischemic conditioning
Interests: Basic science and clinical research in organ protection against acute ischaemia/reperfudion injury with a special focus on cardiac protection and acute inflammation and remodeling; basic science and translational research in atherosclerosis and chronic inflammation processes
Ischemic heart disease (IHD) is a leading cause of death and disability worldwide. Despite intensive experimental research over the last three to four decades, there is currently no effective therapy for protecting the heart following acute myocardial infarction in order to prevent heart failure—termed cardioprotection. Therefore, novel molecular targets for cardioprotection need to be discovered in order to improve clinical outcomes of IHD patients. This is the overall objective of our newly established EU-CARDIOPROTECTION COST Action (CA16225 http://www.cardioprotection.eu/), which comprises a European network of 100 leading cardioprotection researchers, dedicated to realising the therapeutic potential of novel cardioprotective therapies for patient benefit. This will be achieved through the discovery of novel therapeutic targets and strategies for cardioprotection (such as combination multi-targeted therapies), and investigating the confounding effects of co-morbidities and co-medication on cardioprotection.
Therefore, in this Special Issue of IJMS, we invite you to submit both review and original pre-clinical articles on the topic of cardioprotection with a special focus on novel molecular targets for cardioprotection.
Dr. Ioanna Andreadou
Prof. Derek J Hausenloy
Dr. Hector A. Cabrera Fuentes
EU-CARDIOPROTECTION COST Action: CA16225 http://www.cardioprotection.eu/
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Reactive oxygen species
- Cyotprotective signaling pathways
- Ischemia-Reperfusion injury
- Acute myocardial infarction
- Ischemic preconditioning
- Ischemic postconditioning
- Remote ischemic conditioning